Skip to content

Study on the correlation between vitamin K and its dependent protein and coronary artery calcification scores in middle-aged and elderly people

Study on the correlation between vitamin K and its dependent protein and coronary artery calcification scores in middle-aged and elderly people

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043181
Enrollment
Unknown
Registered
2021-02-08
Start date
2021-03-01
Completion date
Unknown
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Interventions

Non-coronary heart disease control group:N/A

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria for non coronary heart disease control population 1. Subjects over 40 years old; 2. Subjects who can sign informed consent voluntarily; 3. Subjects who were healthy in the past and had no complaints of chest tightness or chest pain; 4. Subjects who can exclude coronary heart disease with normal myocardial enzyme spectrum and ECG. Inclusion criteria for coronary heart disease in middle-aged and elderly people 1. According to the 2011 ACCF / AHA guidelines, patients with coronary heart disease diagnosed by coronary angiography or coronary CTA met the diagnostic criteria; 2. Patients over 40 years old; 3. Patients who signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Subjects with chest pain caused by other congenital heart diseases, valvular diseases, severe neurosis, etc.; 2. Subjects in acute stage of cerebral infarction; 3. Subjects with severe primary diseases such as liver, kidney and hematopoietic system; 4. Subjects with acute infection in the last two weeks; 5. Patients with other serious diseases that must be treated (such as hematological diseases, tumors, etc.); Especially in patients with elevated liver cancer markers or history of liver cirrhosis and suspected liver cancer; 6. Subjects taking warfarin and other drugs that affect vitamin K.

Design outcomes

Primary

MeasureTime frame
vitamin k1;vitamin k2;vitamin K-dependent proteins(VKDPs);Coronary Calcification Score;

Secondary

MeasureTime frame
Routine blood;Blood biochemical;Change in polarity of inflammatory cells;Inflammatory factors;

Countries

China

Contacts

Public ContactPang Bo

Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine

pangbo@gamyy.cn+86 10-88001489

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026